STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in
Woman with terminal cancer gets dream wedding on hospital ward
STAT+: Enforcement of stringent Medicaid work requirements delayed for six months
STAT+: Democrats coalesce around ‘Medicare for More,’ ‘Medikids’ proposals
